Mitsuhiro Osame

Q: What Schools Are Affiliated With Mitsuhiro Osame

Mitsuhiro Osame is affiliated with the following schools: Kagoshima University, University of Tokyo, Kumamoto University, Yonsei University

Mitsuhiro Osame's AcademicInfluence.com Rankings

Mitsuhiro Osame

Medical

#1800

World Rank

#2176

Historical Rank

Neurology

#163

World Rank

#232

Historical Rank

medical Degrees

Mitsuhiro Osame

Philosophy

#5388

World Rank

#8166

Historical Rank

Logic

#2677

World Rank

#3701

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Mitsuhiro Osame's Degrees

Doctorate Medicine Kyoto University
PhD Neurology Kyoto University

Why Is Mitsuhiro Osame Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Mitsuhiro Osame's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

HTLV-I ASSOCIATED MYELOPATHY, A NEW CLINICAL ENTITY (1986) (2168)
Spread of HTLV-I Between Lymphocytes by Virus-Induced Polarization of the Cytoskeleton (2003) (714)
Chronic progressive myelopathy associated with elevated antibodies to human T‐lymphotropic virus type I and adult T‐cell leukemialike cells (1987) (638)
CHRONIC INFLAMMATORY ARTHROPATHY ASSOCIATED WITH HTLV-I (1989) (403)
HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. (1999) (399)
Analysis Of Htlv-I Proviral Load In 202 Ham/Tsp Patients And 243 Asymptomatic Htlv-I Carriers: High Proviral Load Strongly Predisposes To Ham/Tsp (1998) (397)
The risk of development of HTLV-I-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I. (1990) (371)
Extrafusal and intrafusal muscle effects in experimental botulinum toxin‐A injection (1996) (333)
Greatly raised vascular endothelial growth factor (VEGF) in POEMS syndrome (1996) (303)
HLA haplotype‐linked high immune responsiveness against HTLV‐I in HTLV‐I‐associated myelopathy: Comparison with adult T‐cell leukemia/lymphoma (1988) (295)
Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. (1999) (295)
Cardiac involvement in mitochondrial diseases. A study on 17 patients with documented mitochondrial DNA defects. (1995) (293)
Abundant tax protein expression in CD4+ T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes. (2000) (289)
Overproduction of vascular endothelial growth factor/vascular permeability factor is causative in crow–fukase (POEMS) syndrome (1998) (282)
Nationwide survey of HTLV‐I–associated myelopathy in Japan: Association with blood transfusion (1990) (264)
Correlation of human T-cell lymphotropic virus type 1 (HTLV-1) mRNA with proviral DNA load, virus-specific CD8(+) T cells, and disease severity in HTLV-1-associated myelopathy (HAM/TSP). (2002) (264)
HTLV-I-associated myelopathy: analysis of 213 patients based on clinical features and laboratory findings. (1995) (246)
Constitutive expression of parathyroid hormone-related protein gene in human T cell leukemia virus type 1 (HTLV-1) carriers and adult T cell leukemia patients that can be trans-activated by HTLV-1 tax gene (1990) (219)
Immunocytochemical Analysis of the Cellular Infiltrate in the Spinal Cord Lesions in HTLV‐I‐Associated Myelopathy (1993) (218)
The Influence of HLA Class I Alleles and Heterozygosity on the Outcome of Human T Cell Lymphotropic Virus Type I Infection1 (2000) (211)
A novel mutation of desert hedgehog in a patient with 46,XY partial gonadal dysgenesis accompanied by minifascicular neuropathy. (2000) (206)
IDENTITY OF HTLV-I-ASSOCIATED TROPICAL SPASTIC PARAPARESIS AND HTLV-I-ASSOCIATED MYELOPATHY (1988) (192)
Cellular immune response to HTLV-1 (2005) (189)
Increased replication of HTLV‐I in HTLV‐I–associated myelopathy (1989) (186)
Detection of human T‐lymphotropic virus type I (HTLV‐I) tax RNA in the central nervous system of HTLV‐I–associated myelopathy/tropical spastic paraparesis patients by in situ hybridization (1995) (184)
Existence of escape mutant in HTLV-I tax during the development of adult T-cell leukemia. (2001) (181)
Paucity and disorganization of presynaptic membrane active zones in the lambert‐eaton myasthenic syndrome (1982) (164)
Interferon-alpha is effective in HTLV-I-associated myelopathy (1996) (160)
BLOOD TRANSFUSION AND HTLV-I ASSOCIATED MYELOPATHY (1986) (159)
Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/ tropical spastic paraparesis. (1996) (153)
Cytokine Expression in the Spinal Cord Lesions in HTLV-l-associated Myelopathy (1994) (148)
[HTLV-I-associated myelopathy]. (1987) (146)
Inhibitory effect of maternal antibody on mother‐to‐child transmission of human T‐lymphotropic virus type I (1991) (144)
Highly concentrated vascular endothelial growth factor in platelets in Crow–Fukase syndrome (2000) (134)
Manganese intoxication during total parenteral nutrition: report of two cases and review of the literature (1999) (130)
VIRUSES DETECTED IN HTLV-I-ASSOCIATED MYELOPATHY AND ADULT T-CELL LEUKAEMIA ARE IDENTICAL ON DNA BLOTTING (1987) (127)
Phylogenetic subgroups of human T cell lymphotropic virus (HTLV) type I in the tax gene and their association with different risks for HTLV-I-associated myelopathy/tropical spastic paraparesis. (2000) (126)
Detection of human T cell lymphotropic virus type I proviral DNA and its gene expression in synovial cells in chronic inflammatory arthropathy. (1991) (126)
Target epitope in the Tax protein of human T-cell leukemia virus type I recognized by class I major histocompatibility complex-restricted cytotoxic T cells (1992) (124)
Clinical features of asthmatic patients with increased urinary leukotriene E4 excretion (hyperleukotrienuria): Involvement of chronic hyperplastic rhinosinusitis with nasal polyposis. (2004) (123)
Mitochondrial encenhdomyopathy with lachte‐pyruvate elevation and brain infarctions (1984) (122)
Myopathy induced by HMG-CoA reductase inhibitors in rabbits: a pathological, electrophysiological, and biochemical study. (1998) (121)
Relative prevalence and risk factors of HTLV-I and HTLV-II infection in US blood donors (1991) (121)
Effects of omega-3 polyunsaturated fatty acids on inflammatory markers in COPD. (2005) (113)
Arthritis in patients infected with human T lymphotropic virus type I. Clinical and immunopathologic features. (1991) (109)
Zidovudine plus lamivudine in Human T-Lymphotropic Virus type-I-associated myelopathy: a randomised trial (2006) (109)
Elevated levels of interleukin-6 in serum and cerebrospinal fluid of HTLV-I-associated myelopathy/tropical spastic paraparesis (1990) (106)
HTLV-I proviral load correlates with progression of motor disability in HAM/TSP: Analysis of 239 HAM/TSP patients including 64 patients followed up for 10 years (2001) (105)
Human T‐lymphotropic virus type I‐associated myelopathy and tax gene expression in CD4+ T lymphocytes (1996) (105)
HTLV-I proviral DNA amount correlates with infiltrating CD4+ lymphocytes in the spinal cord from patients with HTLV-I-associated myelopathy (1994) (102)
Human T-cell leukemia virus type-1 (HTLV-1) Tax is expressed at the same level in infected cells of HTLV-1-associated myelopathy or tropical spastic paraparesis patients as in asymptomatic carriers but at a lower level in adult T-cell leukemia cells. (1995) (100)
Ocular manifestations in patients infected with human T-lymphotropic virus type I. (1989) (98)
Increased serum level of vascular endothelial growth factor in pulmonary tuberculosis. (2000) (97)
Frameshift mutation in the collagen VI gene causes Ullrich's disease (2001) (96)
Midkine is present in the early stage of cerebral infarct. (1995) (96)
Screening of SLC25A13 mutations in early and late onset patients with citrin deficiency and in the Japanese population: Identification of two novel mutations and establishment of multiple DNA diagnosis methods for nine mutations (2002) (95)
Histopathological analysis of four autopsy cases of HTLV-I-associated myelopathy/tropical spastic paraparesis: inflammatory changes occur simultaneously in the entire central nervous system (2000) (93)
Fluctuation of HTLV-I proviral DNA in peripheral blood mononuclear cells of HTLV-I-associated myelopathy (1993) (93)
Inhibition of nonsense‐mediated mRNA decay rescues the phenotype in Ullrich's disease (2004) (93)
Serum levels of vascular endothelial growth factor dependent on the stage progression of lung cancer. (2000) (93)
Specific inhibition of nonsense-mediated mRNA decay components, SMG-1 or Upf1, rescues the phenotype of Ullrich disease fibroblasts. (2006) (90)
"Association of apolipoprotein E allele !e4 with late-onset familial and sporadic Alzheimer's disease": Comment. (1994) (89)
Polygenic control of human T lymphotropic virus type I (HTLV-I) provirus load and the risk of HTLV-I-associated myelopathy/tropical spastic paraparesis. (2002) (88)
Frequent clonal proliferation of human T-cell leukemia virus type 1 (HTLV-1)-infected T cells in HTLV-1-associated myelopathy (HAM-TSP). (1992) (88)
Stromal-derived factor-1alpha/CXCL12-CXCR 4 axis is involved in the dissemination of NSCLC cells into pleural space. (2004) (85)
Apoptosis of T Lymphocytes in the Spinal Cord Lesions in HTLV‐l-Associated Myelopathy: A Possible Mechanism to Control Viral Infection in the Central Nervous System (1994) (85)
Association of AKT1 haplotype with the risk of schizophrenia in Iranian population (2006) (84)
Involvement of enhanced sensitivity of N-methyl-d-aspartate receptors in vulnerability of developing cortical neurons to methylmercury neurotoxicity (2001) (83)
Marked increase of matrix metalloproteinase 9 in cerebrospinal fluid of patients with fungal or tuberculous meningoencephalitis (2000) (83)
Treatment of cerebrotendinous xanthomatosis: effects of chenodeoxycholic acid, pravastatin, and combined use (1994) (82)
A new type of hereditary motor and sensory neuropathy linked to chromosome 3 (1997) (81)
Serum VEGF--as a prognostic factor of atherosclerosis. (2007) (80)
Retinal manifestations in mitochondrial diseases associated with mitochondrial DNA mutation. (1998) (80)
HLA-A*26, HLA-B*4002, HLA-B*4006, and HLA-B*4801 alleles predispose to adult T cell leukemia: the limited recognition of HTLV type 1 tax peptide anchor motifs and epitopes to generate anti-HTLV type 1 tax CD8(+) cytotoxic T lymphocytes. (2001) (79)
Autosomal dominant palatal myoclonus and spinal cord atrophy (2002) (76)
Polyarthritis in human T lymphotropic virus type I-associated myelopathy. (1989) (76)
Marked increase in plasma interleukin-6 in burn patients. (1992) (75)
HTLV-I-associated myelopathy (HAM) treatment trials, retrospective survey and clinical and laboratory findings (1989) (72)
Usefulness of proviral load measurement for monitoring of disease activity in individual patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis (2003) (72)
Expression of adhesion molecules and monocyte chemoattractant protein-1 (MCP-1) in the spinal cord lesions in HTLV-I-associated myelopathy (1996) (72)
Familial spastic paraplegia with mental impairment and thin corpus callosum (1995) (71)
Detection of human T-lymphotropic virus type I p40tax protein in cerebrospinal fluid cells from patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis. (1999) (70)
KIR2DL2 Enhances Protective and Detrimental HLA Class I-Mediated Immunity in Chronic Viral Infection (2011) (69)
TNF-related apoptosis-inducing ligand is involved in neutropenia of systemic lupus erythematosus. (2004) (69)
Treatment and outcome of myasthenia gravis: retrospective multi-center analysis of 470 Japanese patients, 1999–2000 (2004) (68)
A comparative study of eicosanoid concentrations in sputum and urine in patients with aspirin‐intolerant asthma (2002) (68)
Perivascular T cells are infected with HTLV-I in the spinal cord lesions with HTLV-I-associated myelopathy/tropical spastic paraparesis: double staining of immunohistochemistry and polymerase chain reaction in situ hybridization (1998) (68)
Pathological mechanisms of human T-cell lymphotropic virus type I-associated myelopathy (HAM/TSP) (2011) (68)
Differences in viral and host genetic risk factors for development of human T-cell lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis between Iranian and Japanese HTLV-1-infected individuals. (2005) (68)
Isaacs' syndrome as a potassium channelopathy of the nerve (2002) (68)
Arthritis in a human T lymphotropic virus type I (HTLV-I) carrier. (1990) (67)
Mitochondrial DNA mutation correlates with stage progression and prognosis in non‐small cell lung cancer (2003) (64)
Clonal expansion within CD4+ and CD8+ T cell subsets in human T lymphotropic virus type I-infected individuals. (1998) (63)
Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in HTLV-I-associated myelopathy. (1998) (63)
Chronic inflammatory demyelinating polyneuropathy: Histological and immunopathological studies on biopsied sural nerves (1994) (62)
Potassium current suppression in patients with peripheral nerve hyperexcitability. (1999) (61)
Decreased human T lymphotropic virus type I (HTLV-I) provirus load and alteration in T cell phenotype after interferon-alpha therapy for HTLV-I-associated myelopathy/tropical spastic paraparesis. (2004) (61)
Targeted Deletion of Both Thymidine Phosphorylase and Uridine Phosphorylase and Consequent Disorders in Mice (2002) (60)
MOTHER-TO-CHILD TRANSMISSION IN HTLV-I ASSOCIATED MYELOPATHY (1987) (60)
Cytosolic Ca2+ increase and cell damage in L6 rat myoblasts by HMG-CoA reductase inhibitors. (1994) (59)
Clinical electrophysiologic studies of HTLV-I-associated myelopathy. (1987) (59)
Cytotoxic T–cell abundance and virus load in human immunodeficiency virus type 1 and human T–cell leukaemia virus type 1 (2001) (59)
Human T-cell lymphotropic virus type I and neurological diseases (2003) (59)
A prospective uncontrolled trial of fermented milk drink containing viable Lactobacillus casei strain Shirota in the treatment of HTLV-1 associated myelopathy/tropical spastic paraparesis (2005) (58)
Polymorphism in the interleukin-10 promoter affects both provirus load and the risk of human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis. (2004) (56)
Impaired function of human T-lymphotropic virus type 1 (HTLV-1)-specific CD8+ T cells in HTLV-1-associated neurologic disease. (2008) (55)
Neuropathology of HTLV-1-associated myelopathy (HAM/TSP). (1997) (54)
A rat model of human T lymphocyte virus type I (HTLV-I) infection: in situ detection of HTLV-I provirus DNA in microglia/macrophages in affected spinal cords of rats with HTLV-I-induced chronic progressive myeloneuropathy (1999) (54)
Low Levels of Serum Apolipoprotein AI and AII in Senile Dementia (1994) (54)
Geographical subtypes demonstrated by RFLP following PCR in the LTR region of HTLV-I. (1992) (53)
Mechanism of action of voltage‐gated K+ channel antibodies in acquired neuromyotonia (2004) (53)
Electrical myotonia of rabbit skeletal muscles by HMG‐CoA reductase inhibitors (1994) (53)
Inclusion Body Myositis Associated With Human T-Lymphotropic Virus-Type I Infection: Eleven Patients From an Endemic Area in Japan (2008) (51)
HTLV-I-associated myelopathy (HAM), treatment trials, retrospective survey and clinical laboratory findings (1990) (51)
Vascular endothelial growth factor and proinflammatory cytokines in pleural effusions. (2002) (51)
VEGF is causative for pulmonary hypertension in a patient with Crow-Fukase (POEMS) syndrome. (2000) (50)
Genetic control and dynamics of the cellular immune response to the human T-cell leukaemia virus, HTLV-I. (1999) (50)
Increased HTLV type 1 tax specific CD8+ cells in HTLV type 1-asociated myelopathy/tropical spastic paraparesis: correlation with HTLV type 1 proviral load. (2000) (49)
Detection of the soluble form of the Fas molecule in patients with multiple sclerosis and human T-lymphotropic virus type I-associated myelopathy (1997) (48)
Highly accumulated platelet vascular endothelial growth factor in coagulant thrombotic region (2003) (48)
Early clinical signs and imaging findings in Gerstmann–Sträussler–Scheinker syndrome (Pro102Leu) (2006) (48)
Intraventricular administration of the neurotrophic factor midkine ameliorates hippocampal delayed neuronal death following transient forebrain ischemia in gerbils (2001) (47)
Atherogenic risk factors in cerebrotendinous xanthomatosis. (1991) (46)
Serum of Isaacs' syndrome suppresses potassium channels in PC‐12 cell lines (1996) (46)
Failure to detect HTLV‐I by in situ hybridization in the biopsied muscles of viral carriers with polymyositis (1992) (46)
Activated T lymphocytes in cerebrospinal fluid of patients with HTLV-I-associated myelopathy (HAM/TSP) (1989) (46)
Expansion of unstable DNA region in Japanese myotonic dystrophy patients (1992) (46)
Molecular analysis of T cell clonotypes in muscle-infiltrating lymphocytes from patients with human T lymphotropic virus type 1 polymyositis. (2002) (46)
Neuropathology of HTLV‐I‐Associated Myelopathy—A Report of Two Autopsy Cases— (1992) (45)
HTLV‐I‐associated myelopathy (2000) (45)
Expression of vascular endothelial growth factor in tuberculous meningitis (2001) (45)
Gene for hereditary motor and sensory neuropathy (proximal dominant form) mapped to 3q13.1 (1999) (44)
The clinical and pathological features of peripheral neuropathy accompanied with HTLV-I associated myelopathy (2003) (44)
Human T cell leukemia virus type I-infected patients with Hashimoto's thyroiditis and Graves' disease. (2005) (43)
Clinical and pathological studies of familial amyotrophic lateral sclerosis (FALS) with SOD1 H46R mutation in large Japanese families (2003) (42)
Predictive value of serial platelet count and VEGF determination for the management of DIC in the Crow-Fukase (POEMS) syndrome. (2003) (42)
SET binding factor 2 (SBF2) mutation causes CMT4B with juvenile onset glaucoma (2004) (42)
Activation of macrophages/microglia with the calcium-binding proteins MRP14 and MRP8 is related to the lesional activities in the spinal cord of HTLV-I associated myelopathy (1999) (42)
A case of paternally inherited congenital myotonic dystrophy. (1994) (42)
Retinal vasculitis in human T-lymphotropic virus type I associated myelopathy. (1989) (41)
Gap junction protein beta 1 (GJB1) mutations and central nervous system symptoms in X‐linked Charcot–Marie–Tooth disease (2003) (40)
HTLV-I-associated myelopathy (HAM)/tropical spastic paraparesis (TSP) with amyotrophic lateral sclerosis-like manifestations. (2000) (40)
Immunological studies of HTLV-I associated myelopathy. (1988) (39)
Antibodies to potassium channels pc12 in serum of Isaacs' syndrome: Western blot and immunohistochemical studies (1997) (39)
A clinical study of adult human parvovirus B19 infection. (2002) (39)
Clinical phenotype in X-linked Charcot-Marie-Tooth disease with an entire deletion of the connexin 32 coding sequence (2001) (39)
Axonal damage revealed by accumulation of β-amyloid precursor protein in HTLV-I-associated myelopathy (2000) (39)
Bronchoalveolar lymphocytosis correlates with human T lymphotropic virus type I (HTLV-I) proviral DNA load in HTLV-I carriers (2005) (38)
A case of adult-onset Alexander disease with Arg416Trp human glial fibrillary acidic protein gene mutation (2003) (38)
Abnormalities of spinal magnetic resonance images implicate clinical variability in human T-cell lymphotropic virus type I-associated myelopathy (2011) (38)
Low frequency of CD94/NKG2A+ T lymphocytes in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis, but not in asymptomatic carriers. (2003) (37)
Experimental simvastatin-induced myopathy in rabbits (1992) (37)
Antibody reactivities to tumor‐suppressor protein p53 and HTLV‐I Tof, Rex and Tax in HTLV‐I‐infected people with differing clinical status (1997) (37)
MRI studies of spinal visceral larva migrans syndrome (2006) (37)
Phenotypic variation in a large Japanese family with Miyoshi myopathy with nonsense mutation in exon 19 of dysferlin gene (2001) (36)
Degenerate specificity of HTLV-1-specific CD8+ T cells during viral replication in patients with HTLV-1-associated myelopathy (HAM/TSP). (2003) (36)
Human T lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP): recent perspectives. (1995) (36)
Different cytokine production in tax-expressing cells between patients with human T cell lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis and asymptomatic HTLV-I carriers. (2003) (36)
Cardiac dystrophin abnormalities in Becker muscular dystrophy assessed by endomyocardial biopsy. (1995) (35)
Desert hedgehog-patched 2 expression in peripheral nerves during Wallerian degeneration and regeneration (2006) (35)
Effects of thymectomy on late-onset myasthenia gravis without thymoma (2007) (34)
Phenotypes of X-linked Charcot-Marie-Tooth disease and altered trafficking of mutant Connexin 32 (GJB1) (2001) (33)
Abnormal expression of laminin suggests disturbance of sarcolemma-extracellular matrix interaction in Japanese patients with autosomal recessive muscular dystrophy deficient in adhalin. (1994) (33)
Freeze‐fracture electronmicroscopic analysis of plasma membranes of cultured muscle cells in Duchenne dystrophy (1981) (33)
Collagen VI deficiency in Ullrich's disease (2001) (33)
Detection of HTLV‐I provirus by in situ polymerase chain reaction in mononuclear inflammatory cells in skeletal muscle of viral carriers with polymyositis (1995) (31)
Adenosine and neopterin levels in cerebrospinal fluid of patients with neurological disorders. (1999) (31)
Facioscapulohumeral muscular dystrophy: clinical diversity and genetic abnormalities in Japanese patients. (1997) (31)
Study of hereditary cerebellar degeneration in cats. (1996) (31)
Molecular mechanism of rigid spine with muscular dystrophy type 1 caused by novel mutations of selenoprotein N gene (2006) (31)
Immunohistochemical characteristics of polymyositis in patients with HTLV‐1–associated myelopathy and HTLV‐I carriers (1993) (31)
Association of a particular amino acid sequence of the HLA‐DR β1 chain with HTLV‐I‐associated myelopathy (1990) (30)
Frequent mutation in pX region of HTLV-1 is observed in HAM/TSP patients, but is not specifically associated with the central nervous system lesions. (1995) (30)
A case of nemaline myopathy with ophthalmoplegia and mitochondrial abnormalities (1980) (30)
Usefulness of transcutaneous Doppler jugular venous echo to predict pulmonary hypertension in COPD patients. (2001) (29)
Cloning of rat lysosomal acid lipase cDNA and identification of the mutation in the rat model of Wolman's disease. (1995) (29)
Quantitative in situ PCR assay of HTLV-1 infected cells in peripheral blood lymphocytes of patients with ATL, HAM/TSP and asymptomatic carriers (1998) (29)
Activation of Discoidin Domain Receptor 1 on CD14-Positive Bronchoalveolar Lavage Fluid Cells Induces Chemokine Production in Idiopathic Pulmonary Fibrosis 1 (2005) (29)
In vitro modulation of lymphocyte proliferation by prednisolone and interferon-α in patients with HTLV-I-associated myelopathy (HAM) (1989) (29)
Cerebrovascular disorders and genetic polymorphisms: mitochondrial DNA5178C is predominant in cerebrovascular disorders (2002) (29)
A novel MPZ gene mutation in dominantly inherited neuropathy with focally folded myelin sheaths (1999) (28)
Behçet's disease and Sjögren syndrome in a patient with HTLV-I-associated myelopathy (1993) (28)
Safety and efficacy of interferon-α in 167 patients with human T-cell lymphotropic virus type 1-associated myelopathy (2007) (27)
Osteoporosis and increased bone fractures in cerebrotendinous xanthomatosis. (1993) (27)
Accumulation of human T-lymphotropic virus type I (HTLV-I)-infected cells in the cerebrospinal fluid during the exacerbation of HTLV-I-associated myelopathy (2011) (27)
Diseases among men living in human T-lymphotropic virus type I endemic areas in Japan. (1993) (27)
Circulating levels of MMP-1, -2, -3, -9, and TIMP-1 are increased in POEMS syndrome (2001) (27)
Cardiomyopathy, mental retardation, and autophagic vacuolar myopathy Abnormal MRI findings in the head (1991) (27)
Midkine exists in astrocytes in the early stage of cerebral infarction. (1998) (26)
High levels of plant sterols and cholesterol precursors in cerebrotendinous xanthomatosis. (1991) (26)
Mitochondrial myopathy and familial thiamine deficiency (2000) (26)
[HTLV-I-associated myelopathy]. (1999) (26)
Pigmentary retinal degeneration in patients with HTLV-I-associated myelopathy. (1989) (26)
HTLV‐I viral escape and host genetic changes in the development of adult T cell leukemia (2006) (26)
Clinical features of HTLV-I associated uveitis determined in multicenter collaborative study. Study Group for HTLV-I Associated Ocular Diseases. (1994) (26)
Mushroom worker's lung resulting from indoor cultivation of Pleurotus osteatus. (1998) (25)
Molecular analysis of hereditary deficiency of the third component of complement (C3) in two sisters. (2001) (25)
Pathological changes in skeletal muscle in HTLV-I-associated myelopathy (1992) (25)
Miyoshi myopathy patients with novel 5' splicing donor site mutations showed different dysferlin immunostaining at the sarcolemma (2002) (25)
Immunological abnormality in patients with lysinuric protein intolerance (1995) (25)
Myopathy due to glycogen storage disease: pathological and biochemical studies in relation to glycogenosome formation. (1983) (25)
Increased serum high mobility group box‐1 level in Churg–Strauss syndrome THIS ARTICLE HAS BEEN RETRACTED (2007) (25)
Genetic Stability of Human T Lymphotropic Virus Type I despite Antiviral Pressures by CTLs1 (2007) (25)
Altered trafficking and adhesion function of MPZ mutations and phenotypes of Charcot-Marie-Tooth disease 1B (2002) (24)
Cell surface phenotype of in vitro proliferating lymphocytes in HTLV-I-associated myelopathy (HAM/TSP) (1992) (24)
HAM/TSP: recent perspectives in Japan. (1996) (24)
ApaI polymorphism of vitamin D receptor gene is associated with susceptibility to HTLV-1-associated myelopathy/tropical spastic paraparesis in HTLV-1 infected individuals (2005) (24)
Significantly increased antibody response to heterogeneous nuclear ribonucleoproteins in cerebrospinal fluid of multiple sclerosis patients but not in patients with human T-lymphotropic virus type I—associated myelopathy/tropical spastic paraparesis (2011) (24)
Multiple episodes of thrombosis in a patient with Becker muscular dystrophy with marked expression of utrophin on the muscle cell membrane (1999) (24)
Nasu-Hakola disease (membranous lipodystrophy) Clinical, histopathological and biochemical studies of three cases (1989) (24)
Serum levels of apoptosis-related molecules in patients with multiple sclerosis and human T-lymphotropic virus Type I-associated myelopathy. (1999) (24)
The origin of spontaneous discharges in acquired neuromyotonia. A Macro EMG study (2005) (23)
Immune dysfunction in hypophosphatemic vitamin D-resistant rickets: immunoregulatory reaction of 1 alpha(OH) vitamin D3. (1989) (23)
Difference in the relative contribution of lean and fat mass components to bone mineral density with generation (2006) (23)
Limited sequence divergence of HTLV-I of Indian HAM/TSP patients from a prototype Japanese isolate. (1993) (23)
Expression of vascular endothelial growth factor in pulmonary aspergilloma. (2001) (23)
Decreased Total Nitric Oxide Production in Patients with Duchenne Muscular Dystrophy (2004) (23)
Pathological characteristics of skeletal muscle in Ullrich's disease with collagen VI deficiency (2003) (23)
Recent studies on the epidemiology, clinical features and pathogenic mechanisms of HTLV-I associated myelopathy (HAM/TSP) and other diseases associated to HTLV. (1997) (23)
Longer dinucleotide repeat polymorphism in matrix metalloproteinase-9 (MMP-9) gene promoter which correlates with higher HTLV-I Tax mediated transcriptional activity influences the risk of HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP) (2004) (23)
Clinical manifestation of human T-cell lymphotropic virus type-I-associated myelopathy and vesicopathy. (1991) (23)
Motor Nerve Terminal Calcium Channels in Lambert‐Eaton Myasthenic Syndrome (1989) (23)
Diversity of intrathecal antibody synthesis against HTLV-I and its relation to HTLV-I associated myelopathy (1996) (22)
Electrophysiological studies in cerebrotendinous xanthomatosis. (1992) (22)
Study of lower limb somatosensory evoked potentials in 96 cases of HTLV-I-associated myelopathy/tropical spastic paraparesis (1996) (22)
[Viral infections in medicine. 2. The history of discovery and clinico-epidemiology of HTLV-I-associated myelopathy (HAM)]. (1989) (22)
A multicenter case-control study of HTLV-I associated uveitis. Study Group for HTLV-I Associated Ocular Diseases. (1994) (22)
Three cases of juvenile onset HTLV-I-associated myelopathy with pseudohypoparathyroidism (1993) (22)
Germanium myopathy: clinical and experimental pathological studies (2004) (22)
Juvenile form of Alexander disease with GFAP mutation and mitochondrial abnormality (2004) (22)
Involvement of discoidin domain receptor 1 in the deterioration of pulmonary sarcoidosis. (2005) (22)
Apolipoprotein E epsilon 4. (1994) (22)
Treatment of cerebrotendinous xanthomatosis with low-density lipoprotein (LDL)-apheresis (1993) (21)
The agonist of the protease-activated receptor-1 (PAR1) but not PAR3 mimics thrombin-induced vascular endothelial growth factor release in human vascular smooth muscle cells (2003) (21)
Reduced Foxp3 expression with increased cytomegalovirus-specific CTL in HTLV-I-associated myelopathy (2008) (21)
Discoidin domain receptor 1 contributes to the survival of lung fibroblast in idiopathic pulmonary fibrosis. (2006) (21)
Type II muscle fibers are stained by anti-Fas antibody (1995) (21)
Frequent reversible membrane damage in peripheral blood B cells in human T cell lymphotropic virus type I (HTLV‐I)‐associated myelopathy/tropical spastic paraparesis (HAM/TSP) (2000) (21)
The main HTLV-I-harboring cells in the muscles of viral carriers with polymyositis are not macrophages but CD4+ lymphocytes (1996) (21)
Two cases of acute exacerbation of interstitial pneumonia treated with polymyxin B-immobilized fiber column hemoperfusion treatment. (2007) (21)
Increased serum vascular endothelial growth factor level in Churg-Strauss syndrome. (2006) (21)
Clinical course of HTLV-I-associated uveitis. (1999) (21)
The effects of shounousui on the three responses of the blink reflex in man (1997) (21)
Influence of human T lymphotrophic virus type I on cryptogenic fibrosing alveolitis − HTLV‐I associated fibrosing alveolitis: proposal of a new clinical entity (2003) (20)
Autosomal dominant early onset dementia and leukoencephalopathy in a Japanese family: clinical, neuroimaging and genetic studies (1997) (20)
Increased expression of thrombomodulin on the cultured human umbilical vein endothelial cells and mouse hemangioma cells by cyclic AMP. (1991) (20)
Electron microscopic abnormalities of skeletal muscle in patients with collagen VI deficiency in Ullrich's disease (2002) (20)
CD8 positive T-cell infiltration in the dentate nucleus of paraneoplastic cerebellar degeneration (2009) (20)
Bronchiectasis with myeloperoxidase antineutrophil cytoplasmic antibody and bactericidal/permeability-increasing protein antineutrophil cytoplasmic antibody. (1999) (20)
Apolipoprotein E ε4 (1994) (20)
Characterization of a unique T-cell clone established from a patient with HAM/TSP which recognized HTLV-I-infected T-cell antigens as well as spinal cord tissue antigens (1996) (20)
Altered expression of atrial natriuretic peptide and contractile protein genes in hypertrophied ventricle of JVS mice with systemic carnitine deficiency. (1997) (20)
Myocardial patchy staining of dystrophin in Becker's muscular dystrophy associated with cardiomyopathy. (1992) (20)
Hereditary motor and sensory neuropathy with myelin folding and juvenile onset glaucoma (2000) (20)
Outbreak of Bronchiolitis obliterans Associated with Consumption of Sauropus androgynus in Japan – Alert of Food-Associated Pulmonary Disorders from Japan (2005) (20)
Different manners of sarcoglycan expression in genetically proven α-sarcoglycan deficiency and γ-sarcoglycan deficiency (1998) (19)
HTLV-1 associated myelopathy (HAM). (1988) (19)
Preferential recognition of synthetic peptides from HTLV-I gp21 envelope protein by HLA-DRB1 alleles associated with HAM/TSP (HTLV-I-associated myelopathy/tropical spastic paraparesis) (1997) (19)
Cerebrotendinous xanthomatosis: cranial CT and MRI studies in eight patients (2004) (19)
Purified protein derivative of tuberculin upregulates the expression of vascular endothelial growth factor in T lymphocytes in vitro (2002) (19)
Diagnosis of dystrophinopathy by skin biopsy (2002) (19)
Polyneuropathy induced by m-tolyl methyl carbamate intoxication (1991) (19)
Allogenic bone marrow transplantation as a treatment for adult T-cell leukemia. (1999) (19)
In Vivo Selection of T-Cell Receptor Junctional Region Sequences by HLA-A2 Human T-Cell Lymphotropic Virus Type 1 Tax11-19 Peptide Complexes (2001) (19)
Posterior interosseous nerve syndrome with hourglass-like fascicular constriction of the nerve (2003) (19)
CD44 splice variant involvement in the chronic inflammatory disease of the spinal cord: HAM/TSP (2000) (18)
Immunogenetic factors involved in the pathogenesis of adult T-cell leukemia and HTLV-I-associated myelopathy (1992) (18)
Contralateral early blink reflex in patients with HTLV-I associated myelopathy/tropical spastic paraparesis (1995) (18)
An overexpression of fibroblast growth factor (FGF) and FGF receptor 4 in a severe clinical phenotype of facioscapulohumeral muscular dystrophy (2000) (18)
[HTLV-I-associated myelopathy (HAM)]. (1990) (18)
Experimental germanium myopathy (2004) (18)
[HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP)]. (1997) (18)
Paraneoplastic vasculitic neuropathy: immunohistochemical studies on a biopsied nerve and post‐mortem examination (1994) (18)
Increased levels of soluble Fas ligand in CSF of rapidly progressive HTLV-1-associated myelopathy/tropical spastic paraparesis patients (1999) (18)
Predictive value of the prolonged exercise test in hypokalemic paralytic attack (1995) (17)
[Serum lipids, lipoproteins and apolipoproteins in patients with senile dementia]. (1992) (17)
Human T-cell lymphotropic virus type-I (HTLV-I)-associated myelopathy/tropical spastic paraparesis with acute type of adult T-cell leukemia. (1995) (17)
Vesnarinone inhibits production of HIV-1 in cultured cells. (1993) (17)
Pulmonary manifestations in cerebrotendinous xanthomatosis. (1998) (17)
HLA class I and class II of the Nivkhi, an indigenous population carrying HTLV-I in Sakhalin, Far Eastern Russia. (1998) (17)
Germline mosaicism of MPZ Gene in Dejerine-Sottas syndrome (HMSN III) associated with hereditary stomatocytosis (1999) (17)
Phenøtypes and mitochondrial DNA substitutions in families with A3243G mutation (2002) (17)
Cardiac involvement in congenital myopathy. (1985) (17)
Fine mapping of 16q-linked autosomal dominant cerebellar ataxia type III in Japanese families (2004) (16)
Long‐term follow‐up of patients with Duchenne muscular dystrophy receiving ventilatory support (1993) (16)
Polyneuropathy with minifascicle formation in a patient with 46XY mixed gonadal dysgenesis (1999) (16)
Dual Effect of AMD3100, a CXCR4 Antagonist, on Bleomycin-Induced Lung Inflammation1 (2007) (16)
Increased expression of TRAIL receptor 3 on eosinophils in Churg-Strauss syndrome. (2007) (16)
High CSF lactate and pyruvate content in Kearns‐Sayre syndrome (1984) (16)
Mucolipidosis III (pseudo-Hurler polydystrophy); clinical studies in aged patients in one family (1997) (16)
Human T-cell lymphotropic virus type I (HTLV-I)-related clinical and laboratory findings for HTLV-I-infected blood donors. (2003) (16)
A clinical study on hereditary progressive neurogenic muscular atrophy in Pointer dogs. (1978) (16)
Expression of Midkine in Regenerating Skeletal Muscle Fibers and Cultured Myoblasts of Human Skeletal Muscle (2002) (16)
Abnormal expression of proteoglycans in Ullrich's disease with collagen VI deficiency (2006) (16)
Histopathological and ultrastructural features of feline hereditary cerebellar cortical atrophy: a novel animal model of human spinocerebellar degeneration (1998) (16)
The effects of tobacco smoking on the short, middle, and long latency responses of the blink reflex in humans. (1997) (16)
Fibronectin receptor reduction in skin and fibroblasts of patients with Ullrich's disease (2002) (15)
How helpful is thoracic paraspinal EMG in HAM/TSP? (1995) (15)
Analysis of CCG repeats in Huntingtin gene among HD patients and normal populations in Japan. (2008) (15)
Leber's hereditary optic neuropathy: mitochondrial and biochemical studies on muscle biopsies. (1987) (15)
Complete response to twice-a-day interferon-beta with standard interferon-alpha therapy in acute hepatitis C after a needle-stick. (1999) (15)
HTLV-I and Behçet's disease. (1993) (15)
Two cases of idiopathic CD4+ T-lymphocytopenia in elderly patients. (1998) (15)
[Treatment of spastic paraparesis with botulinum toxin with reference to beneficial effects, disease severity and long-term treatment]. (1995) (15)
Human T cell lymphotropic virus type I (HTLV-I) p12I is dispensable for HTLV-I transmission and maintenance of infection in vivo. (2004) (15)
Familial mitochondrial encephalomyopathy with deaf‐mutism, ophthalmoplegia and leukodvstrophy. (1995) (15)
Levodopa in pregnancy. (1997) (15)
Nationwide survey of neurologic manifestations of acquired immunodeficiency syndrome in Japan. (1997) (15)
Long-term follow-up study of health status in population living in methylmercury-polluted area. (2005) (14)
Mutation rates in LTR of HTLV-1 in HAM/TSP patients and the carriers are similarly high to Tax/Rex-coding sequence. (1996) (14)
Anti-viral and immunomodulatory effects of interferon-α on cultured lymphocytes from patients with human T lymphotropic virus type I-associated myelopathy (HAM/TSP) (1995) (14)
Midkine (MK) expression in extraembryonic tissues, amniotic fluid, and cerebrospinal fluid during mouse embryogenesis. (1995) (14)
Cross-Sectional Analysis of Neurological Findings among Healthy Elderly: Study in a Remote Island in Kagoshima, Japan (2001) (14)
Differential effect of TGF-beta 1 on the in vitro activation of HTLV-I and the proliferative response of CD8+ T lymphocytes in patients with HTLV-I-associated myelopathy (HAM/TSP). (1995) (14)
Determining the optimal time for peripheral blood stem cell harvest by detecting immature cells (immature leukocytes and immature reticulocytes) using two newly developed automatic cell analyzers. (1997) (14)
Ex vivo analysis of human T lymphotropic virus type 1-specific CD4+ cells by use of a major histocompatibility complex class II tetramer composed of a neurological disease-susceptibility allele and its immunodominant peptide. (2007) (14)
Review : Abnormalities in the protein C anticoagulant pathway detected by a novel assay using human thrombomodulin (1997) (14)
Parkinsonism in cerebrotendinous xanthomatosis. (1991) (14)
Unilateral toe-walking secondary to intramuscular hemangioma in the gastrocnemius (2005) (13)
Neurologic manifestations of Kanzaki disease (2004) (13)
[5 cases of dystonia with marked diurnal fluctuation and special reference to homovanillic acid in CSF]. (1984) (13)
cis-Acting inhibitory elements within the pol-env region of human T-cell leukemia virus type 1 possibly involved in viral persistence (1997) (13)
First missense mutations (R388W and R425H) of AMPD1 accompanied with myopathy found in a Japanese patient (2000) (13)
Mitochondrial abnormalities in extraocular muscles in myotonic dystrophy (1989) (13)
Degradative activity of granzyme A on skeletal muscle proteins in vitro: A possible molecular mechanism for muscle fiber damage in polymyositis (1993) (13)
Adult onset limb-girdle type mitochondrial myopathy with a mitochondrial DNA np8291 A-to-G substitution (1999) (13)
Minifascicular neuropathy: a new concept of the human disease caused by desert hedgehog gene mutation. (2002) (13)
Identification of a novel mutation (Tyr1081Ter) in sisters with hereditary component C3 deficiency and SLE‐like symptoms (2001) (13)
Human T‐lymphotropic virus type I‐associated myelopathy/tropical spastic paraparesis and systemic lupus erythematosus (1997) (13)
Acute disseminated myelitis after Japanese B encephalitis vaccination (1997) (13)
Three silent periods in the orbiculari oculi muscles of man: normal findings and some clinical vignettes. (2001) (13)
Werner's syndrome associated with spastic paraparesis and peripheral neuropathy (1993) (13)
Chronic progressive cervical myelopathy with HTLV-I infection (2004) (13)
[A case of pulmonary infiltration with eosinophilia caused by Ascaris suum]. (1998) (13)
Clinical symptoms and the odds of human T-cell lymphotropic virus type 1-associated myelopathy/ tropical spastic paraparesis (HAM/TSP) in healthy virus carriers: Application of best-fit logistic regression equation based on host genotype, age, and provirus load (2006) (13)
Adult T-cell leukemia (ATL) cells which express neural cell adhesion molecule (NCAM) and infiltrate into the central nervous system. (2002) (12)
Hyponatremia upon resumption of paroxetine therapy. (2005) (12)
Stereometric estimation of the area of the freeze‐fractured membrane (1982) (12)
Clinical investigation of pulmonary Mycobacterium avium complex infection in human T lymphotrophic virus type I carriers. (2000) (12)
Influence of human T lymphotrophic virus type I on diffuse pan‐bronchiolitis (2004) (12)
[Bronchopneumonopathy in HTLV-1 associated myelopathy (HAM) and non-HAM HTLV-1 carriers]. (1992) (12)
Capillary changes in skeletal muscle of patients with Ullrich's disease with collagen VI deficiency (2003) (12)
Human T lymphotropic virus type I neurotropism. (1990) (12)
Fatigue and damage to the masseter muscle by prolonged low-frequency stimulation in the rat. (2005) (12)
Selective matrix metalloproteinase inhibitor, N-biphenyl sulfonyl phenylalanine hydroxamic acid, inhibits the migration of CD4+ T lymphocytes in patients with HTLV-I-associated myelopathy (2002) (12)
The history of discovery and clinico-epidemiology of HTLV-I-associated myelopathy(HAM). (1989) (12)
Intrathecal humoral immune response in HAM/TSP in relation to HLA haplotype analysis (1996) (12)
Different manners of sarcoglycan expression in genetically proven alpha-sarcoglycan deficiency and gamma-sarcoglycan deficiency. (1998) (12)
Different pattern of HSP47 expression in skeletal muscle of patients with neuromuscular diseases (2007) (12)
Machado–Joseph disease with retinal degeneration and dementia (2001) (11)
Mononeuropathy associated with hyperthyroidism. (1990) (11)
Familial facioscapulohumeral muscular dystrophy: phenotypic diversity and genetic abnormality (1996) (11)
Myoadenylate deaminase deficiency with progressive muscle weakness and atrophy caused by new missense mutations in AMPD1 gene: case report in a Japanese patient (2000) (11)
HTLV-1–associated myelopathy/tropical spastic paraparesis with pseudohypoparathyroidism (2001) (11)
Relapsing cervical cord lesions on MRI in patients with HTLV-I–associated myelopathy (2006) (11)
Expression of the heparin-binding growth factor midkine in the cerebrospinal fluid of patients with neurological disorders. (2008) (11)
[Respiratory failure and its care in Duchenne muscular dystrophy]. (1991) (11)
Waardenburg syndrome: a variant with neurological involvement. (1987) (11)
Experimental germinaium dioxide-induced neuropathy in rats (2004) (11)
Instability of R3 response of the blink reflex in patients with HAM/TSP. (1994) (10)
An autopsied case of the Crow-Fukase syndrome: a neuropathological study with emphasis on spinal roots (1987) (10)
Myopathic changes at the end-plate region induced by neostigmine methylsulfate (1976) (10)
Human T-cell lymphotropic virus type 1 can infect primary rat retinal glial cells and induce gene expression of inflammatory cytokines. (1997) (10)
Characteristic expression of cell adhesion molecules in adhalin deficiency (1996) (10)
Statistically significant differences in the number of CD24 positive muscle fibers and satellite cells between sarcoglycanopathy and age-matched Becker muscular dystrophy patients. (1999) (10)
[Lysosomal glycogen storage disease without acid maltase deficiency]. (1995) (10)
Experimental Nemaline Rods Induced by Anticholinesterase Drug (Neostigmine Methylsulfate) (1975) (10)
Patients with homocystinuria: high metal concentrations in hair, blood and urine (1992) (10)
[Case of hypertrophic meningitis with vasculitis syndrome]. (1994) (10)
Maternal-fetal mercury transport and fetal methylmercury poisoning. (1997) (10)
Involvement of Fas/Fas ligand system in the spinal cords of HTLV-I-associated myelopathy (2002) (10)
Dominantly inherited motor and sensory neuropathy with excessive myelin folding complex (2004) (10)
Familial skeletal myopathy with atrioventricular block. (1999) (10)
Activation of discoidin domain receptor 1 on CD14-positive bronchoalveolar lavage fluid cells induces chemokine production in idiopathic pulmonary fibrosis (Journal of Immunology (2005) 174, (6490-6498)) (2008) (10)
Glycogen storage disease. Studies related to the mechanism of glycogenosome formation. (1983) (10)
[A case of rapidly progressive HTLV-I-associated myelopathy (HAM)]. (1997) (10)
Abnormal expression of heparan sulfate proteoglycan on basal lamina of muscle fibers in two Japanese patients with adhalin deficiency (1995) (10)
Morphologic findings in biopsied skeletal muscle and cultured fibroblasts from a female patient with Danon's disease (lysosomal glycogen storage disease without acid maltase deficiency) (1994) (10)
Hypercholestanolemia in Diagnosing Cerebrotendinous Xanthomatosis vs. Familial Hypercholesterolemia, Primary Biliary Cirrhosis, and Hypothyroidism (1990) (9)
Molecular pathologic analysis of the tonsil in HTLV-I-infected individuals. (1999) (9)
New missense mutation in the alpha-sarcoglycan gene in a Japanese patient with severe childhood autosomal recessive muscular dystrophy with incomplete alpha-sarcoglycan deficiency (1997) (9)
[Medullary infarction due to vertebral dissecting aneurysm in a patient with Behçet's disease]. (1996) (9)
Lack of evidence for HTLV-II infection in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in an endemic area. (1993) (9)
Chronic sensory ataxic neuropathy and ophthalmoplegia with oculomotor nerve hypertrophy associated with IgM antibodies against gangliosides containing disialosyl groups. (1997) (9)
Chronic demyelinating neuropathy and intra-axonal polyglucosan bodies (2004) (9)
Chronic progressive sensory ataxic neuropathy associated with limited systemic sclerosis (2006) (9)
HTLV-I-associated myelopathy (HAM): epidemiology, clinical features, and pathomechanism (1992) (9)
Human T-lymphotropic virus type I infections in western India. (1993) (9)
Neutral oligosaccharides in the urine of a patient with glycogen storage disease type II. (1985) (9)
Mechanomyographic determination of post-activation potentiation in myopathies (2006) (9)
[A study on the frequency of von Willebrand factor deficiency state]. (1991) (8)
Benign monoclonal T cell proliferation in HTLV-I infection. (1993) (8)
A new mutation (LIPA Tyr22X) of lysosomal acid lipase gene in a Japanese patient with Wolman disease. (1996) (8)
Immunocytochemical Study on Endothelial Markers with the Cerebral Vessel from a Patient with Familial Moyamoya Disease (1991) (8)
Retraction: Use of tiotropium bromide for pre-operative treatment in chronic obstructive pulmonary disease patients: comparison with oxitropium bromide. (2008) (8)
Accumulation of mitochondrial ATP synthase subunit c in muscle in a patient with neuronal ceroid lipofuscinosis (late infantile form) (1997) (8)
Morphological and histochemical study of nonhemiplegic muscle in acute stroke patients manifesting respiratory failure. (1996) (8)
A new mutation (LIPA Tyr22X) of lysosomal acid lipase gene in a Japanese patient with Wolman disease (1996) (8)
Canine storage disease characterized by hereditary progressive neurogenic muscular atrophy: breeding experiments and clinical manifestation. (1986) (8)
Increased serum vascular endothelial growth factor levels in microscopic poly angiitis with pulmonary involvement. (2006) (8)
Electroencephalographic abnormalities in human T-cell lymphotropic virus type I-associated myelopathy. (1989) (8)
Vacuolar myositis with expression of both MHC class I and class II antigens on skeletal muscle fibers (1991) (8)
PS-56-10 X-linked dystonia parkinsonism: botulinum toxin therapy and stimulation single-fiber electromyography (1995) (8)
Adult T‐cell leukemia predominantly involving exocrine glands (2004) (8)
[Magnetic resonance imaging findings of HTLV-I-associated myelopathy]. (1989) (7)
Morphometric anlysis of intramuscular nerves (1985) (7)
Pleural cryptococcosis with idiopathic CD4 positive T-lymphocytopenia. (2004) (7)
Hyperestrogenemia in neuromuscular diseases (1989) (7)
Pulmonary dirofilariasis with serologic study on familial infection with Dirofilaria immitis. (2004) (7)
HTL V-I from Iranian Mashhadi Jews in Israel is phylogenetically related to that of Japan, India, and South America rather than to that of Africa and Melanesia (2005) (7)
Predominant expression of Fas ligand mRNA in CD8+ T lymphocytes in patients with HTLV-1 associated myelopathy (1998) (7)
Symposium on viral infections in medicine. 2. The history of discovery and clinicoepidemiology of HTLV-I-associated myelopathy(HAM). (1988) (7)
Detection of HTLV type I provirus by in situ polymerase chain reaction in mouthwash mononuclear cells of HAM/TSP patients and HTLV type I carriers. (1997) (7)
Steroid-responsive myalgia in a patient with Becker muscular dystrophy (1993) (7)
Acute dapsone-induced peripheral neuropathy. (1989) (7)
Multiple Sclerosis and HTLV-I associated myelopathy/tropical spastic paraparesis are two distinct clinical entities (1996) (7)
Adhesion to Fibronectin Regulates Expression of Intercellular Adhesion Molecule-1 on Eosinophilic Cells (1999) (7)
Detection of DNA fragmentation of myonuclei in myotonic dystrophy by double staining with anti-emerin antibody and by nick end-labeling (2000) (7)
Aspirin induces short-chain free fatty acid accumulation in rats. (1998) (7)
Serum amyloid A and P protein levels are lowered by dextran sulfate cellulose low-density lipoprotein apheresis. (1998) (7)
Alteration of cytokine levels by fosfomycin and prednisolone in spontaneous proliferation of cultured lymphocytes from patients with HTLV-I-associated myelopathy (HAM/TSP) (1997) (7)
[Genetically confirmed spinal muscular atrophy type III with epilepsy, cerebral hypoperfusion, and parahippocampal gyrus atrophy]. (2000) (7)
In vitro virus propagation and high cellular responsiveness to the infected cells in patients with HTLV-I-associated myelopathy (HAM/TSP) (1997) (7)
[A case of congenital antithrombin III deficiency complicated by an internal carotid artery occlusion]. (1986) (6)
A kinetic comparative study on lymphocyte responses to superantigen and phytohemagglutinin: reciprocal presentation of superantigen on the surface of activated lymphocytes. (1996) (6)
Neuropathology of human T lymphotropic virus type I‐associated myelopathy (1997) (6)
HTLV-I-associated myelopathy and adult T-cell leukemia cases in a family. (1989) (6)
[Muscle type acid maltase deficiency. An intermediate case between childhood type and adult type (author's transl)]. (1982) (6)
Eosinophilic pneumonia with eosinophilic gastroenteritis. (1999) (6)
Phenotypic Duchenne muscular dystrophy with C-terminal domain. (1992) (6)
[A case of tuberculous abscess in the chest wall close to the thickening pleural lesion following tuberculous pleuritis]. (1997) (6)
Computed tomography in fetal methylmercury poisoning. (1993) (6)
Morphometry of intramuscular nerves in amyotrophic lateral sclerosis (1988) (6)
Mimicry between HTLV-I and myelin basic protein: no response in HTLV-I-associated myelopathy patients (1992) (6)
Genetic variability in the extracellular matrix protein as a determinant of risk for developing HTLV-I-associated neurological disease (2006) (6)
Matsuyama et al. TNF-related apoptosis-inducing ligand is involved in neutropenia of systemic lupus erythematosus. Blood. 2004;104:184-191. (2008) (6)
A C77G point mutation in CD45 exon 4, which is associated with the development of multiple sclerosis and increased susceptibility to HIV‐1 infection, is undetectable in Japanese population (2003) (6)
HTLV-I associated myelopathy (HAM): review and recent studies. (1997) (6)
PET scan study on the dopaminergic system in a Japanese patient with hereditary progressive dystonia (Segawa's disease). Case report. (1993) (6)
A patient with acute-onset HAM/TSP after blood transfusion complicated with pseudopseudohypoparathyroidism. (2002) (6)
Necrotising vasculitis with conduction block in mononeuropathy multiplex with cold agglutinins (1999) (6)
[A possible case of drug-induced pneumonia due to L-carbocisteine]. (2007) (6)
Risk factors in normolipidemic male patients with coronary artery disease in Japanese. (1992) (6)
Expression of thrombomodulin, caveolin‐3, and desmin on muscle fibers in neuromuscular diseases (1999) (6)
Human T-cell lymphotropic virus type I and systemic lupus erythematosus. (1999) (5)
Killer cell immunoglobulin‐like receptor/3DL2 expression in adult T‐cell leukaemia (2007) (5)
Blood Dolichols in a Patient with Abetalipoproteinaemia (1999) (5)
Characteristic Expression of Thrombomodulin in the Muscle Sarcoplasm in Patients with the Acute Phase of Rhabdomyolysis (2000) (5)
Use of tiotropium bromide for pre-operative treatment in chronic obstructive pulmonary disease patients: comparison with oxitropium bromide. (2007) (5)
[The recent advances of HAM/TSP research]. (1999) (5)
Increased prevalence of group A β-hemolytic streptococcus among an ethnic population in Kyrgyzstan detected by the rapid antigen detection test. (2008) (5)
Changes in serum lipoprotein(a) and C4b-binding protein levels after acute myocardial infarction. (1992) (5)
Type IIa hyperlipoproteinemia masquerading as cerebrotendinous xanthomatosis (1989) (5)
[Hypothyroidism with increased serum levels of cholestanol and bile alcohol--analogous symptoms to cerebrotendinous xanthomatosis]. (1991) (5)
Enhanced inhibition of lymphocyte activation byMycobacterium avium complex in human T lymphotrophic virus type I carriers (2001) (5)
Role of Kenae/CCDC125 in cell motility through the deregulation of RhoGTPase. (2009) (5)
Chronic progressive cervical myelopathy with HTLV-I infection: Variant form of HAM/TSP? (2005) (5)
Logistic model analysis of neurological findings in Minamata disease and the predicting index. (2002) (5)
Flow cytometry evaluation of the T-cell receptor Vβ repertoire among human T-cell lymphotropic virus type-1 (HTLV-1) infected individuals: Effect of interferon alpha therapy in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) (2006) (5)
Stimulation single fibre EMG study in a patient with Schwartz-Jampel syndrome. (1996) (5)
Clinical neurophysiological comparative study on HTLV-1 associated myelopathy/tropical spastic paraparesis. (1995) (4)
Assessment of mitochondrial gene in proliferative vitreoretinal tissues from patients with familial diabetes mellitus. (1996) (4)
Partial characterization of leucocyte alpha-glucosidase in late onset glycogenosis type II. (1989) (4)
[Clinical and myopathological findings in polymyositis]. (1987) (4)
LATE PHASE SPONTANEOUS PROLIFERATION OF CULTURED PERIPHERAL BLOOD LYMPHOCYTES ASSOCIATED WITH HTLV-I INFECTION (1996) (4)
Hermansky-Pudlak syndrome with a novel mutation. (2005) (4)
Genetic control and dynamics of the cellular immune response to HTLV-I (1999) (4)
Multifocal relapsing-remitting myelitis in a patient with atopic dermatitis: multiple sclerosis or atopic myelitis? (2002) (4)
Pathogenesis and treatment of human T-cell lymphotropic virus Type I-associated myelopathy (2002) (4)
Notice of retraction: Increased expression of TRAIL receptor 3 on eosinophils in Churg-Strauss syndrome (Arthritis Rheum 2007;56:662-73). (2008) (4)
Autoproliferative and self-reactive T-cell lines from patients with HTLV-I-associated myelopathy. (1990) (4)
[Mitochondrial encephalomyopathy with multiple brain infarcts]. (1985) (4)
Idiopathic hypoparathyroidism with fungal seminal vesiculitis. (1997) (4)
Effects of LDL-apheresis on serum lipoprotein (a), C4b binding protein, protein C, protein S, and complement components. (1994) (4)
[Juvenile Binswanger-type encephalopathy with alopecia and spondylosis deformans--a case report]. (1993) (4)
[A study of mitochondrial electron transfer chain in myotonic dystrophy]. (1989) (4)
[Two lung adenocarcinoma patients with multiple brain metastasis treated with Gefitinib and surviving more than 2 years]. (2006) (4)
Characteristics of dynamic mutation in Japanese myotonic dystrophy (1994) (4)
Microvascular endothelial abnormality in skeletal muscle from a patient with gastric cancer without dermatomyositis (2000) (4)
Idiopathic CD4+ T-lymphocytopenia in chronic obstructive pulmonary disease. (1999) (4)
[Tropical spastic paraparesis (HAM/TSP) in different regions of the world. Subclinical and geographic differences in neurophysiologic studies]. (1994) (4)
Iodine-123 iodobenzofuran (I-123 IBF) SPECT in patients with parkinsonism (1999) (4)
[Significance of anti-HTLV-I antibody in cerebrospinal fluid in diagnosis of HTLV-I associated myelopathy (HAM)]. (1992) (4)
HTLV‐I‐associated myelopathy, tropical spastic paraparesis and Borrelia burgdorferi (1990) (4)
Cytotoxic and suppressor activities in patients with HTLV-I-associated myelopathy (1991) (3)
[Acute isolated levator palpebral myositis]. (1998) (3)
Lymphocyte α-Glucosidase in Late-Onset Glycogenosis Type II (1989) (3)
Ehlers-Danlos syndrome combined with von Recklinghausen neurofibromatosis. (1992) (3)
A spontaneous point mutation in the human T-cell leukemia virus type 1 pX gene leads to expression of a novel doubly spliced pX-mRNA that encodes a 25-kD, amino-terminal deleted rex protein. (1994) (3)
[A case of adrenoleukomyeloneuropathy(ALMN) with pseudobulbar symptom--predominancy case of brainstem and cerebellum atrophies]. (1986) (3)
A hemophiliac with human immunodeficiency virus (HIV)-1-associated dementia complex. (1995) (3)
Schwartz-Jampel syndrome associated with von Willebrand's disease (2004) (3)
[Diagnosis and treatment of HTLV-I associated myelopathy]. (1990) (3)
[Intense 18F-fluorodeoxyglucose uptake caused by pulmonary Mycobacterium intracellulare infection]. (2004) (3)
Normal sural nerve morphometry in acute uraemia. (1987) (3)
[Occurrence of subdural hematoma closely associated with danazol administration in a patient with refractory ITP]. (1990) (3)
Dystrophin-related protein in Becker muscular dystrophy. (1994) (3)
[Dermal application of lisuride on parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the common marmoset and on cases with Parkinson's disease]. (1998) (3)
HTLV-I and HTLV-II (2004) (3)
[A case of pleuritis caused by strongyloides in a carrier of T-cell lymphoma virus type I (HTLV-I)]. (1998) (3)
Muscular involvement in lysosomal acid lipase deficiency in rats (1992) (3)
Living-donor lobar lung transplantation in Sauropus androgynus-associated bronchiolitis obliterans in Japan. (2005) (3)
Hereditary Motor and Sensory Neuropathy with Proximal Dominant Involvement: Clinical, Pathological, and Genetic Features (1999) (3)
[Two cases of facial diplegia with elevated serum antibodies to Borrelia burgdorferi]. (1989) (3)
Deletion in chromosome 17p11.2 including the peripheral myelin protein-22 (PMP-22) gene in hereditary neuropathy with liability to pressure palsies (1995) (3)
The past, the present and the future of HAM/TSP research (1999) (3)
Retraction: Suppression of Discoidin Domain Receptor 1 by RNA Interference Attenuates Lung Inflammation (2008) (3)
[Chronic progressive external ophthalmoplegia (CPEO); mitochondrial DNA deletion, brain MRI and electrophysiological studies]. (1991) (3)
Morphological study on the hereditary neurogenic amyotrophic dogs: Accumulation of lipid compound-like structures in the lower motor neuron (2004) (3)
[Symptomatic adrenoleukodystrophy heterozygote with fluctuated neurological symptoms--a case report]. (1991) (3)
[Pulmonary sclerosing hemangioma with specific CT findings]. (1998) (3)
Bucillamine may induce myasthenia gravis. (1991) (3)
[Recent progress of molecular immunology on inflammatory myopathy]. (1997) (3)
Serum concentration and genetic polymorphism in the 5′-untraslated region of VEGF is not associated with susceptibility to HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP) in HTLV-I infected individuals (2004) (3)
IgM‐containing fraction suppressed voltage‐gated potassium channels in acquired neuromyotonia (2006) (3)
[HTLV-I-associated myelopathy]. (1987) (3)
[A case of bronchiolitis obliterans syndrome successfully treated by Tiotropium bromide]. (2006) (3)
Protective effect of MK-801 in methyl mercury induced neuronal injury (1998) (3)
Caveolin‐3 and sarcoglycans in the vacuolar myopathies and centronuclear myopathy (1999) (3)
Lymphocyte subsets in muscle biopsies of human T-lymphotropic virus type I carriers with polymyositis. (1992) (3)
Depression of neuromuscular transmission in methylmercury‐poisoned rats: a glass microelectrode and single fiber electromyography study (1997) (3)
Concentration of activated t lymphocytes in extracorporeal blood circulation for plasma separation (1991) (3)
Sequence analysis of human T cell lymphotropic virus type I (HTLV-I) Env genes amplified from central nervous system tissues of patients with HTLV-I-associated myelopathy or leukemia. (1995) (2)
New mutation of gap junction protein β1 (GJB1) gene in X‐linked hereditary motor and sensory neuropathy (2006) (2)
In situ polymerase chain reaction detection of HTLV-I provirus and expression of the p53 tumor suppressor gene in infiltrating cells in skeletal muscle from a patient with adult T cell leukemia (2004) (2)
[Juvenile parkinsonism in monozygotic twins]. (1991) (2)
[Chronic interstitial pneumonia and crescentic glomerulonephritis associated with perinuclear antineutrophil cytoplasmic antibodies]. (1997) (2)
CHANGES AT THE NEUROMUSCULAR JUNCTIONS IN THE AFFECTED MUSCLES OF NEOSTIGMINE-TREATED RATS, TENOTOMIZED RATS AND A PATIENT WITH NEMALINE MYOPATHY (1977) (2)
[A case of nemaline myopathy with core/targetoid fibers and lobulated fibers (author's transl)]. (1980) (2)
PS-19-8 Isaacs syndrome as a channelopathy of voltage dependent potassium channel (1995) (2)
PS-19-10 Antibodies to potassium channel in Isaacs syndrome and other neurological disorders (1995) (2)
Isolated medial medullary infarction due to vertebral artery dissection (2003) (2)
Morphometric analysis of intramuscular nerves. (1985) (2)
APOLIPOPROTEIN E EPSILON 4. AUTHORS' REPLY (1994) (2)
Immunohistochemical demonstration of acid α-glucosidase in muscle in Pompe's disease (1983) (2)
EXPERIMENTAL MYOPATHY INDUCED BY NEOSTIGMINE METHYLSULPHATE (1975) (2)
[A case of nemaline myopathy with ophthalmoplegia and mitochondrial abnormalities (author's transl)]. (1978) (2)
Hereditary motor and sensory neuropathy associated with juvenile glaucoma. (2001) (2)
Histochemical and ultrastructural pathology of skeletal muscle in a patient with abetalipoproteinemia (2004) (2)
Data-processing method for standardization of thermographic diagnosis (2000) (2)
[New accompaning signs and symptoms of adrenoleukodystrophy. --Adrenoleukomyeloneuropathy with hypoparathyroidism, cerebral calcification, and frequent yawning--(author's transl)]. (1982) (2)
Failure to detect HTLV type 1 DNA from HTLV type 1-seronegative patients with chronic progressive spastic paraparesis in Kagoshima. (2002) (2)
The correlation between erythropoiesis and thrombopoiesis as an index for pre-operative autologous blood donation. (1999) (2)
Angiographic Morphology of the Posterior Communicating Artery and Basilar Artery in Patients with ICA-PComA Aneurysm (1991) (2)
[Frequency and clinical significance of congenital plasminogen abnormality in cerebral infarction]. (1986) (2)
[Cerebrotendinous xanthomatosis--a case of brain MRI abnormality and osteoporosis]. (1992) (2)
[Blood coagulation studies in a family with congenital plasminogen abnormality--with a special relevance to the association of thrombotic tendency with abnormal plasminogen]. (1986) (2)
T lymphocyte infiltration in the minor salivary glands of patients with HTLV-I associated myelopathy (1991) (2)
Sural nerve morphology in asymptomatic uremia. (1988) (2)
Lymphocyte alpha-glucosidase in late-onset glycogenosis type II. (1989) (2)
Clinical and morphometric analysis of biopsied biceps brachii muscles in adult-onset chronic proximal spinal muscular atrophy. With special reference to intramuscular nerves. (1988) (2)
[Advanced stage of giant axonal neuropathy]. (1991) (2)
Pleural cryptococcosis with idiopathic CD4 positive T-lymphocytopenia. (2004) (2)
[A case of scapuloperoneal atrophy with rigid spine having lobulated fibers in muscle biopsy]. (1991) (2)
Evaluation of usefulness of anti-HTLV-I antibody titer measurement in the spinal fluid for establishing diagnosis of HAM/TSP (1999) (2)
Synovial fluid T cells in HTLV-I positive RA. (1993) (2)
[Successful lobectomy in 3 lung cancer cases with severe COPD after treatment with tiotropium bromide]. (2007) (1)
INFLAMMATORY CHANGES IN HAM/TSP OCCUR SIMULTANEOUSLY IN THE ENTIRE CNS: HISTOPATHOLOGIC ANALYSIS OF FOUR AUTOPSY CASES (1999) (1)
[Bronchial asthma attack with lactic acidosis and hypokalemia in a case receiving high dose inhalation of procaterol hydrochloride]. (2007) (1)
Choroideremia with leukoencephalopathy and arylsulfatase A pseudodeficiency (1996) (1)
Increased frequency of CD4+T cells expressing fractalkine receptor CX3CR1 in patients with HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP), but its AIDS susceptible polymorphisms are not associated with the disease (2008) (1)
Retraction: Dual Effect of AMD3100, a CXCR4 Antagonist, on Bleomycin-Indiced Lung Inflammation (2008) (1)
[Clinical investigation of three cases of pulmonary eosinophilic granuloma]. (1997) (1)
Leber's hereditary optic neuropathy: mitochondrial andbiochemical studies onmuscle biopsies (2011) (1)
Lymphocyte subsets in sural nerves from patients with vasculitic neuropathy. (1991) (1)
The platelet level indicates the erythropoietic capacity for preoperative autologous blood donation. (1999) (1)
[A case of paranasal sinusitis-cavernous sinusitis with ophthalmoplegia externa]. (1996) (1)
[Collagen adhesion abnormality]. (1986) (1)
[The effect of cigarettes on somatosensory potentials]. (1998) (1)
Real defect of AMPD1 accompanied with myopathy: new missense mutations found in a Japanese patient (1999) (1)
[Therapeutic effect of lymphocytapheresis on patients with HTLV-I-associated myelopathy (HAM)]. (1992) (1)
[Progressive hereditary neurogenic muscular atrophy in dogs of the pointer breed]. (1978) (1)
[Adult-onset neuronal ceroid lipofuscinosis--a case report with biological study]. (1992) (1)
An autopsy case of peripheral neuroepithelioma in posterior mediastinum with p53 point mutation. (1998) (1)
Alteration of T cell subsets by filtration through positively charged fibers (1992) (1)
[A family with von Willebrand disease and hypofibrinogenemia]. (1990) (1)
[Clinical investigation of 15 patients with pulmonary cryptococcosis--clinical comparison of HTLV-I carriers and non-carriers]. (1999) (1)
[Recent advance in neuroimmunology]. (1998) (1)
[Nationwide survey of necrotizing myelopathy associated with malignancy in Japan]. (1991) (1)
Leucocyte alpha-1,4- and alpha-1,6-glucosidase activities towards oligosaccharides in late onset glycogenosis type II. (1990) (1)
[Glycogenosis type III with peripheral nerve disorder and muscular hypertrophy in an adult]. (1983) (1)
[Pure red cell aplasia with monoclonal gammopathy and von Willebrand disease]. (1990) (1)
A case of HTLV-I associated myelopathy(HAM) in Korea. (1991) (1)
[Markedly elevated serum neopterin levels in patients with hemophagocytic histiocytosis]. (1992) (1)
[Clinical and epidemiological studies on inpatients with dementia]. (1990) (1)
0331 Desert hedgehog-patched2 expression in peripheral nerves during wallerian degeneration and regeneration (2005) (1)
[A patient of ADEM with central and peripheral conduction block improved with ultra-high-dose methylprednisolone]. (2002) (1)
RECURRENCE OF CHICKENPOX IN AN ACYCLOVIR‐TREATED PATIENT (1997) (1)
[Clinical aspects of mitochondrial encephalomyopathy--abnormality of mitochondrial respiratory chain]. (1990) (1)
[Paroxysmal dystonic choreoathetosis with chronic hemolytic anemia and morphologically abnormal erythrocytes]. (1995) (1)
Letters to the editor (1991) (1)
[A case of destructive thyroiditis complicated with ACTH deficiency]. (1991) (1)
[Increase of serum acidic isoferritins in patients with hemophagocytic histiocytosis]. (1990) (1)
[Plasma concentrations of plasminogen activator inhibitor 2 in patients with hematological malignancies and their clinical significance]. (1991) (1)
[Idiopathic interstitial pneumonia that responded to intermittent intravenous administration of high-dose cyclophosphamide]. (1994) (1)
IMMUNOHISTOCHEMICAL STUDY OF CYTOCHROME COXIDASE WITH A MONOCLONAL ANTIBODY IN MITOCHONDRIAL MYOPATHY (1988) (1)
Pathogenic mechanisms of HTLV-I associated myelopathy (HAM/TSP) and other disease associated to HTLV-I (1998) (1)
[Efficacy of leukocytapheresis and low-dose prednisolone treatment in a patient with HTLV-I-associated myelopathy (HAM)]. (1990) (1)
Molecular pathological comparison of primary gastric B-celllymphomas in China and Japan: Polymerase chain reaction (PCR) analysis of immunoglobulin heavy chain gene variable region and direct sequencing of the product (1999) (1)
[Therapy for HAM/TSP and AIDS]. (1994) (1)
Annulate lamellae‐soleplate nuclei associations in skeletal muscle fibers of rats during chronic high‐dose exposure to neostigmine (1989) (1)
[A case of pharyngeal-cervical-brachial variant of Guillain-Barré syndrome with positive anti-galactocerebroside (Gal-C) IgM antibody]. (1999) (1)
Pyroantimonate deposition patterns observed in the motor endplate myopathy following esterase inactivation. (1986) (1)
[Familial hyperkalemic periodic paralysis: a brief review of the adult human skeletal muscle sodium channel and the application of LA-PCR to the SCN4A gene analysis]. (1997) (1)
Apolipoprotein E Polymorphism and Late Onset Alzheimer's Disease In (2003) (1)
[Vascular endothelial growth factor and Crow-Fukase syndrome]. (2001) (1)
Determination of urine thiocyanate in patients with amyotrophic lateral sclerosis (1984) (1)
Possible HLA association with susceptibility to HTLV-1 tropical spastic paraparesis in Israel in Iranian Jews as compared to HTLV 1-associated myelopathy in Japan. (1996) (1)
[A case of motor neuron disease with IgM gammopathy which showed anti-cerebrum antibody]. (1992) (1)
Lyme disease acquired outside of Japan. (1992) (1)
[Oligoclonal IgG bands in patients with HTLV-I associated myelopathy--detection by agarose isoelectric focusing, transfer to cellulose nitrate and immunoperoxidase staining]. (1989) (1)
Hereditary motor and sensory neuropathy with proximal dominant involvement: clinical, pathological, and genetic features. (1999) (1)
[The significance and limit of thermography at present]. (1992) (1)
Nucleotide sequence analysis of HTLV-I isolate from a Korean patient with HAM/TSP. (1993) (1)
Neuropathy in HTLV-I associated myelopathy (HAM) (1993) (1)
Angiographic morphology of the posterior communicating artery and basilar in patients with ICA-PComA aneurysm. (1991) (1)
[Crow-Fukase (POEMS) syndrome]. (2000) (1)
Muscular Power of Truncal Extension and Flexion in Patients with HAM (2000) (1)
[Clinical characteristics of anti-phospholipid antibodies]. (1990) (1)
[Two cases of HTLV-I associated myelopathy (HAM) complicated with Sjögren's syndrome, T-lymphocyte alveolitis and arthropathy]. (1990) (1)
Reflux of HTLV-I infected lymphocytes from the privileged compartment(s) to peripheral blood flow in patients with HTLV-I-associated myelopathy (1998) (1)
Retraction: Activation of Discoidin Domain Receptor 1 on CD14-Positive Bronchoalveolar Lavage Fluid Cells Induces Chemokine Production in Idiopathic Fibrosis (2008) (1)
Lack of anti‐Coxiella burnetii seropositivity in patients with HTLV‐I‐associated myelopathy (1994) (0)
A Case of Cutaneous T-cell Lymphoma Associated with Paraneoplastic Cerebellar Degeneration (2003) (0)
[Interferon therapy for demyelinating disease]. (1995) (0)
Clinical and morphological approaches to disorders of neuromuscular transmission (1984) (0)
7. Adverse Effects of Dietary Supplements (2007) (0)
[A case of mitochondrial encephalomyopathy (MELAS) with abnormality of the electron transfer chain]. (1987) (0)
Neuropathology of HAM/TSP; Subsets of Cellular Infiltrates and Detection of HTLV-I provirus in the spinal cord lesion (1995) (0)
[Isaacs' syndrome]. (2000) (0)
PS-50-3 Improved decremental responses in hemiplegic limbs of two patients with myasthenia gravis and cerebral infarction (1995) (0)
[A case of hypopituitarism associated with the syndrome of inappropriate secretion of antidiuretic hormone]. (1971) (0)
[Impaired platelet response to thromboxane A2 in a patient with a bleeding disorder]. (1986) (0)
Studies on the blood coagulation and fibrinolytic system in patients with cerebrovascular disease at chronic stage (1987) (0)
Preclinical detection in Japanese families with myotonic dystrophy using polymorphic DNA markers (1989) (0)
Alcohol as a friend of my life (2006) (0)
[A case of Kearns-Sayre syndrome with elevated lactate and pyruvate levels in the cerebrospinal fluid]. (1985) (0)
[n-Hexane polyneuropathy presenting with CIDP-like features]. (2006) (0)
[Diabetic neuropathy--diagnosis, classification and therapy]. (1991) (0)
Genetic Segregation Of Atl And Ham/tsp In Japanese And Colombian Patients (1993) (0)
In Replay: Renin-Angiotensin System Blockade and COPD (2006) (0)
Immunohistochemical demonstration of acid alpha-glucosidase in muscle in Pompe's disease. (1983) (0)
[Effects of danazol on plasma levels of protein S C4b-binding protein]. (1990) (0)
Chapter 4 Ion channel disorders in neuropathy (2002) (0)
Anti-lymphocyte natibodies and circulating immune complexes in the sera of patients with myelopathy associated with human T lymphotropic virus type_I (1993) (0)
[A case of spinal stenosis in acromegaly]. (1990) (0)
[Multiple sclerosis viewed from the point of HTLV-I associated myelopathy]. (1995) (0)
Letter to the editor (1989) (0)
[Case of anti-neutrophilic cytoplasm antibody-positive SLE succumbing to massive pulmonary hemorrhage]. (1993) (0)
HLA-A*02 PROTECTS AGAINST HAM/TSP BY REDUCING HTLV-I PROVIRUS LOAD. (1999) (0)
[Important nervous system infections--human T-lymphotrophic virus type I-associated myelopathy/ tropical spastic paraparesis]. (1996) (0)
Subject Index Vol. 120, Suppl. 1, 1999 (1999) (0)
REVERSIBLE MEMBRANE DAMAGE OF B CELL IN HAM/TSP (1999) (0)
[Major drug-induced lung diseases: Adverse effects of dietary supplements]. (2007) (0)
Glycoconjugate Histochemistry of Membranous Structures of NASU Disease (1987) (0)
Chasing a Dream for Life (2009) (0)
ANALYSIS OF CLINICAL FEATURES AND HTLV-I PROVIRAL LOAD IN HTLV-I SEROPOSITIVE PATIENTS PRESENTING AMYOTROPHIC LATERAL SCLEROSIS (ALS) -LIKE MANIFESTATIONS (1999) (0)
Increased expression of TNF-related apoptosis inducing ligand receptor 3 on eosinophils in Churg-Strauss syndrome (2006) (0)
Neurological manifestations of HTLV-I infection (2002) (0)
[Ion channels and disorders of the peripheral nerve]. (1997) (0)
TELOMERASE ACTIVITY AND TELOMERES IN PERIPHERAL BLOOD MONONUCLEAR CELLS FROM PATIENTS WITH ATL AND HAM/TSP (1999) (0)
Plasma Levels of Thrombin-antithrombin III Complex and β-thromboglobulin during the Presence of Anti-phospholipid Antibodies (1991) (0)
Notices of Meetings (1979) (0)
Decreased decremental response on the hemiparetic side in a patient with myasthenia gravis (MG) complicated by cerebral infarction (1996) (0)
Immunogenetics of HTLV-I infection (1999) (0)
PRIMARY DEMYELINATION OF THE SPINAL CORD AND ADULT T-CELL LEUKEMIA (ATL): AN AUTOPSY CASE OF ACUTE TRANSVERSE MYELOPATHY WITH ATL INVASION. (1999) (0)
HLA-DRB1*0101 POSITIVITY IN HTLV-I INFECTED INDIVIDUALS MAY ACCELERATE DEVELOPMENT OF HAM/TSP (1999) (0)
IN SITU PCR DEMONSTRATION OF HTLV-I INFECTED CELLS IN THE INFLAMED SYNOVIAL TISSUES OF HTLV-I INFECTED INDIVIDUALS. (1999) (0)
A case of HTLV-I-associated myelopathy with IgA nephropathy and pseudohypoparathyroidism type 1. (1991) (0)
HISTOCHEMICAL ANALYSES IN THE SOLEUS MUSCLE OF RATS TREATED WITH NEOSTIGMINE (1979) (0)
Skeletal muscle abnormalities in two patients with dystonia (2002) (0)
[A case of mitochondrial encephalomyopathy with decreased cytochrome c oxidase]. (1987) (0)
[Adrenal tuberculosis with consciousness disturbance]. (2007) (0)
[A study of clinical symptoms, muscle pathology, therapeutic response, and prognosis of myositis in patients with HTLV-1 associated myelopathy (HAM)]. (1999) (0)
Sinobronchial Syndrome. Clinicopathology and Macrolide Therapy. (1995) (0)
[The biochemical and pathological study in a long survival case (author's transl)]. (1981) (0)
[Two new forms of familial motor neuron diseases found in southern Japan]. (1986) (0)
Identification of (23S)-5 alpha-cholestane-3 alpha,7 alpha,12 alpha,23,25-pentol in urine of patients with cerebrotendinous xanthomatosis. (1991) (0)
(HAM-TSP) (HTLV-1)-infected T cells in HTLV-1-associated myelopathy Frequent clonal proliferation of human T-cell leukemia virus type 1 (2011) (0)
Expression of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in HTLV-l-associated Myelopathy (1998) (0)
replication in patients with HTLV-I-associated myelopathy ( HAM / TSP ) Degenerate specificity of HTLV-I-specific CD 8 + T cells during viral (2002) (0)
Type I-Infected Individuals VirusCell Subsets in Human T Lymphotropic T + and CD 8 + Clonal Expansion Within CD 4 (1998) (0)
Failure to detect HTLV-I proviral DNA in the liver of a patient with primary biliary cirrhosis and HTLV-I-associated myelopathy. (1996) (0)
The Effect of Dextran Sulfate Cellulose-LDL Apheresis on Lp (a), Complements, Complement Cofactors and Serum Amyloid Proteins(LDL Apheresis,General Presentation,Proceedings of the Thirteenth Annual Meeting of Japanese Society for Apheresis) (1994) (0)
Lipoprotein metabolism in L6 (rat myoblast) cells (1994) (0)
Idiopathic Pulmonary Fibrosis Cells Induces Chemokine Production in CD14-Positive Bronchoalveolar Lavage Fluid Activation of Discoidin Domain Receptor 1 on (2005) (0)
[Peculiar increase of plasma plasminogen activator inhibitor 1 levels in patients with hemophagocytic histiocytosis]. (1990) (0)
Clinical Genetic Study on Female Duchenne (or Duchenne-like) Muscular Dystrophy (1987) (0)
A Study on the Antithrombotic Effect of Danazol (1990) (0)
[Two cases of type II thrombasthenia]. (1986) (0)
[Mitochondrial encephalomyopathy with elderly onset of psychiatric disorder]. (2007) (0)
Potassium channel suppression as a photomechanism of myokymic discharge (1995) (0)
[A case of myastenia gravis with Basedow's disease, treated by subtotal thyroidectomy]. (1987) (0)
[A case of glossopharyngeal neuraligia with cardiovascular syncope]. (1986) (0)
Letter to the editor (1997) (0)
Human acid maltase‐deficient myogenic cell transformation with origin‐defective SV40: Characterization of a cloned line (1991) (0)
DEMONSTRATION OF UNINTEGRATED HTLV-I IN CULTURED HTLV-I INFECTED CELL LINE. (1999) (0)
[Diagnosis and treatment of HAM]. (1998) (0)
[Carcinomatous neuropathy]. (1989) (0)
Immunopathology of HTLV-I-associated myelopathy (1999) (0)
HTLV-1感染による培養末梢血リンパ球の遅発自発増殖現象:感染細胞に対する細胞性免疫応答の存在 (1996) (0)
High prevalence of herpes virus type 2 infection in Okinawa. (1991) (0)
[The role of immunology in the nervous system]. (1993) (0)
Naturally occuring mutations of HTLV-1 proviral genome within HAM/TSP patients and asymptomatic carriers; the influence of proviral load, host genotype and disease state. (1999) (0)
TREATMENT OF HAM/TSP WITH A COMBINATION OF ZIDOVUDINE AND INTERFERON-α (1999) (0)
[Clinical features of allergic granulomatosis and angiitis (Churg-Strauss syndrome). Association with asthma symptoms]. (1996) (0)
[Changes in the neuromuscular junction and striated muscle fiber following the administration of neostigmine methylsulfate in rats. A morphological observation (author's transl)]. (1975) (0)
[Collagen adhesion-aggregation abnormality (2nd report)--congenital platelet membrane glycoprotein VI deficiency]. (1990) (0)
A GENETIC EPIDEMIOLOGICAL STUDY OF HTLV-I INFCTION IN SOUTHERN JAPAN: A CANDIDATE GENE APPROACH. (1999) (0)
Contents, Vol. 111, Supplement 1, 1996 (1996) (0)
Analysis of Basigin Knockout Mice (1996) (0)
In memoriam: Akihiro Igata, MD, PhD (1928–2016) (2017) (0)
Killer Cell Immunoglobulin-Like Receptor Genotype and HTLV-1 Associated Disease’s Susceptibilities. (2005) (0)
PS-50-5 Depression of neuromuscular transmission in methylmercury poisoned rat: intracellular glass-microelectrode and single fiber electromyography study (1995) (0)
[Accessory use of protease-inhibiting agents for disease remission in a patient with autoimmune hemolytic anemia associated with B-CLL]. (1990) (0)
Inflammation Antagonist , on Bleomycin-Induced Lung Dual Effect of AMD 3100 , a CXCR 4 (2007) (0)
Immunologic mechanisms in neurologic and psychiatric disease (research publications: Association for research in nervous and mental disease, vol. 68) edited by Byron H. Waksman, Raven Press, 1990. $144.00 (xxv + 336 pages) ISBN 0 88167 593 8 (1991) (0)
[A case of combined abnormalities with plasminogen abnormality, type IIA von Willebrand disease, hypofibrinogenemia and hemolysis]. (1986) (0)
Mutation and Polymorphism Report (2000) (0)
DETECTION OF HTLV-I p40tax PROTEIN IN CEREBROSPINAL FLUID CELLS FROM PATIENTS WITH HAM/TSP (1999) (0)
Upregulation of thrombomodulin on human cultured umbilical vein endothelial cells by cAMP (1991) (0)
[A case of aspergillus bronchitis with effective oral itraconazole]. (2003) (0)
EXPANDING SARCOPLASMIC MASSES AND INTRANUCLEAR RODS AT THE ENDPLATE OF TENOTOMIZED SOLEUS MUSCLE (1978) (0)
[New clinical tests in diagnosis of neuro-muscular diseases]. (1993) (0)
Effects of Niceritrol on Lipoprotein (a), C 4b Binding Protein, Serum Amyloid P Protein, and Serum Amyloid A Protein in Cerebrovascular Diseases (1993) (0)
Morphometry of peripheral nerves in acute renal failure (1987) (0)
[Increased complexes between protease and protease inhibitor in the plasma from patients with neoplasm]. (1988) (0)
[A case of dipterex poisoning. A histopathological study of peripheral nerves]. (1982) (0)
REDUCED LEVELS OF PROTEINS INVOLVED IN Aβ CLEARANCE IN SERUM FOLLOWED BY ATROPHY OF THE MEDIAL TEMPORAL STRUCTURES IN THE AFTERMATH OF THE EARTHQUAKE (2019) (0)
Two cases of male hypogonadal osteoporosis (1989) (0)
[Clinical effects of antithrombotic agents in a case of congenital antithrombin III deficiency]. (1986) (0)
Poster abstractIncreased cytosolic calcium ion and cell damage induced by HMG-CoA reductase inhibitors (1994) (0)
PILOT TRIAL OF NUCLEOTIDE ANALOGUES IN THE TREATMENT OF HAM/TSP (1999) (0)
Histopathology of feline hereditary cerebellar cortical atrophy(Second report) (1997) (0)
Serum osteocalcin in patients with immobilization osteoporosis due to Duchenne muscular dystrophy (1989) (0)
[Polyneuropathy in carbamate (m-tolyl methylcarbamate) poisoning]. (1987) (0)
[Hyperestrogenemia in Duchenne muscular dystrophy (DMD)]. (1985) (0)
Morphogenesis of nuclear inclusions in the soleplate region of rat skeletal muscle fibers following chronic daily administration of neostigmine (1989) (0)
[Occurrence of hemophilia A and von Willebrand disease in the same family]. (1990) (0)
Markedly Reduced Plasma Free Protein S Levels in Patients with Hemophagocytic Histiocytosis (1991) (0)
The Neurological and Psychiatric Manifestations of Collagen Diseases (1974) (0)
LACK OF HTLV-I TAX BINDING MOTIFS IN HLA CLASS I MOLECULES IS ASSOCIATED WITH RISK OF ATL (1999) (0)
[A case of scapuloperoneal dystrophy having "cartwheel fibers" (author's transl)]. (1978) (0)
AGGRECAN GENETIC POLYMORPHISM AND ITS RELATION TO THE PATHOGENESIS OF HAM (1999) (0)
Letter: Experimental myopathy induced by neostigmine methylsulphate. (1975) (0)
[Combined abnormalities of plasminogen abnormality, von Willebrand disease, hypofibrinogenemia and increased erythrocyte membrane fragility. A new hereditary syndrome?]. (1986) (0)
CLINICAL NEUROPHYSIOLOGIC FINDINGS IN PATIENTS WITH HAM/TSP (1999) (0)
cDNA cloning of lysosomal acid lipase (LAL) and its mutation in rats with inherited LAL deficiency (1994) (0)
AUGMENTATIVE EFFECTS OF HTLV-I INFECTION ON INFLAMMATORY CHANGES IN PATIENTS WITH KNEE JOINT DISEASES (1999) (0)
[Impairment of the motor endplate]. (1982) (0)
GENETIC EPIDEMIOLOGY STUDY OF HTLV-1 IN SOUTHERN JAPAN:USE OF A CANDIDATE GENE APPROACH (1999) (0)
Disease states and treatment of HAM. (2003) (0)
[A case of myasthenia gravis complicated by cortisol-producing adrenal adenoma]. (1984) (0)
In vivo induction of human immunodeficiency virus type 1 entry into nucleus-free cells by CD4 gene transfer to hematopoietic stem cells: a hypothetical possible strategy for therapeutic intervention. (2002) (0)
Beh et's disease and Sj6gren syndrome in a patient with HTLV-I-associated myelopathy (1993) (0)
[An autopsied case of Crow-Fukase syndrome. A neuropathological study with emphasis on spinal roots]. (1987) (0)
Serum apolipoproteins in Alzheimer's disease and vascular dementia (1994) (0)
[Coincidental occurrence of idiopathic thrombocytopenic purpura in a patient with familial von Willebrand disease]. (1990) (0)
THE TEN YEARS PROJECT FOR CONTROLING THE ENDEMIC OF ADULT T-CELL LEUKEMIA IN KAGOSHIMA PREFECTURE (1999) (0)
STUDY OF CYTOCHROME C OXIDASE WITH A MONOCLONAL ANTIBODY IN MITOCHONDRIAL MYOPATHY (2009) (0)
Arthritis ina humanT lymphotropic virus typeI (HTLV-I) carrier (1990) (0)
BYSTANDER ENCEPHALITIS INDUCED BY MT-2 CELL INNOCULATION IN THE BRAIN OF MICE PREIMMUNIZED WITH HTLV-I ANTIGEN. (1999) (0)
[A novel assay for detecting the thrombomodulin-protein C/S anticoagulant pathway using human thrombomodulin (prothrombinase assay)]. (1997) (0)
FC29.1 Anti-voltage gated potassium channel (VGKC) antibodies associated limbic encephalitis in Japan: Clinical presentation and patch-clamp study (2006) (0)
[Two cases of multiple epiphyseal dysplasia with autonomic dysfunction such as hypohidrosis and orthostatic hypotension in a family]. (1988) (0)
HAM (HTLV-I-ASSOCIATED MYELOPATHY) (1998) (0)
Changes in the Plasma Levels of Coagulation Regulatory Factors in Patients with Nephrotic Syndrome (1991) (0)
Fatty Acid Metabolism and Aspirin in Reye's Syndrome(part 1 of the parts 1 and 2) (2000) (0)
[Bernard-Soulier syndrome with special reference to platelet-membrane glycoprotein abnormalities]. (1986) (0)
Suppression of lymphocyte spontaneous proliferative response by proteolipid protein peptide in patients with HAM/TSP (1994) (0)
Brother cases of multiple epiphyseal dysplasia with autonomic dysfunction such as hypohidrosis and orthostatic hypotension. (1988) (0)
[In situ PCR detection of HTLV-1 provirus in spinal cord lesions with HAM/TSP]. (1996) (0)
Morphological characteristics of the motor endplate myopathy observed in the soleplate sarcoplasm after chronic neostigmine treatment. (1986) (0)
[The clinical features of HTLV-I infection. HTLV-I associated myelopathy]. (1992) (0)
Neuro-immunological complications of retroviruses other than the HIV (1993) (0)
[A case of Werner syndrome associated with spastic paraparesis and peripheral neuropathy]. (1993) (0)
[A recurrent case of subacute necrotizing lymphadenitis]. (1988) (0)
Suppression of Lymphocyte Spontaneous Response by Proteolipid Protein Peptide HAM/TSP* Proliferative in Patients with (1994) (0)
Altered serum levels of proteins involved in beta‐amyloid clearance in the aftermath of the Kumamoto magnitude 7.3 earthquake (2020) (0)
Hereditary Cerebellar Degeneration in Cat : Initial event of Purkinje cell degeneration appeared in distal dendrite (1996) (0)
Multimodal Evoked Potential Studies in Patients with a Myelopathy Associated with the Human T-Lymphotrophic Virus Type I (1988) (0)
Acid maltase deficiency:clinical, morphological and biochemical observation. (1982) (0)
Genetic analysis of Gastric B-cell lymphoma : Application of cycle sequencing technique with fluorescent dyes (1999) (0)
[Concepts and future prospects in HTLV-I-associated myelopathy]. (1988) (0)
ANALYSIS OF CLINICAL FEATURES AND LABORATORY FINDINGS IN 317 PATIENTS WITH HAM AND 10 YEAR-FOLLOW UP STUDY OF 64 PATIENTS WITH HAM (1999) (0)
AUTOPSY REPORT OF A FAMILIAL HOCM PATIENT WHO SHOWED THE FEATURES OF DCM IN THE LATER STAGE : THE 5th CONFERENCE ON CARDIOMYOPATHY (1984) (0)
OCCULT DIFFUSE INVOLVEMENT OF SUPRATENTORIAL WHITE MATTER DETECTED BY MAGNETIC RESONANCE IMAGING IN HTLV-I CARRIERS (1994) (0)
Polyarthralgia in Familial Hypercholesterolemia: A Case Report on Inflammatory Enthesopathy (1992) (0)
[Contribution of Japanese researchers to progress in the field of neurology in the last 100 years: HTLV-I-associated myelopathy (HAM)]. (2002) (0)
Seroepidemiologic study of visceral larva migrans due to Ascaris suum in Kagoshima, Kyushu, Japan (1998) (0)
The effect of bromocriptine on auditory event-related P300 in patients with parkinsonism (1995) (0)
THE ROLE OF THE DESERT HEDGEHOG SIGNALING PATHWAY DURING DEGENERATION AND REGENERATION OF PERIPHERAL NERVES (2004) (0)
A novel primer extension method to detect the number of CAG repeats in the androgen receptor gene in families with X-linked spinal and bulbar muscular atrophy. (1992) (0)
CYTOTOXIC T-CELL FREQUENCY AND LYMPHOCYTE ACTIVATION PHENOTYPE ARE CORRELATED WITH HTLV-I PROVIRAL LOAD (1999) (0)
Report on a pending question 5. Disease state and treatment of HAM. (2003) (0)
6th Meeting of the Neuroepidemiology Section of the Italian Neurological Society (1991) (0)
[Clinical and histochemical findings in spinal muscular atrophy]. (1992) (0)
CD44 SPLICE VARIANTS INVOLVEMENT IN THE PATHOGENESIS OF HAM/TSP (1999) (0)
MOLECULAR PATHOLOGY OF HTLV-I-ASSOCIATED MYELOPATHY/TROPICAL SPASTIC PARAPARESIS (2003) (0)
Desert hedgehog-patched2 expression in peripheral nerves during Wallerian degeneration and regeneration (2005) (0)
[Fetal survival after the corticosteroid and low-dose aspirin regimen in a case of anti-phospholipid antibody syndrome]. (1990) (0)
Cytotoxic T-cell abundance and virus load in human immunode ciency virus type 1 and human T-cell leukaemia virus type 1 (2001) (0)
Degenerative Neurological Diseases in the Elderly (1986) (0)
[Physiopathology and treatment of HAM]. (2003) (0)
[Detection of HTLV-I proviral DNA by PCR method from bronchoalveolar lavage cells of HTLV-I carriers]. (1994) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Mitsuhiro Osame?

Mitsuhiro Osame is affiliated with the following schools:

Mitsuhiro Osame's Academic­Influence.com Rankings

Mitsuhiro Osame's Degrees

Why Is Mitsuhiro Osame Influential?

Mitsuhiro Osame's Published Works

Published Works

What Schools Are Affiliated With Mitsuhiro Osame?

Mitsuhiro Osame's AcademicInfluence.com Rankings